Skip to main content
. 2016 Summer;15(3):379–391.

Table 9.

Prediction result on artificial sample and commercial samples obtained with PLS1, PCR and HLA methods for montelukast. Concentration values are expressed as mgL−1.




Predicted

Sample No. Actual PLS1 PCR HLA
Art 1a 4.00 4.06±0.07 (101.50) b 4.06±0.07 (101.50) 4.12±0.11 (103.00)
Art 2 5.00 5.02±0.17 (100.40) 5.15±0.17 (103.00) 5.03±0.14 (100.60)
Art 3 7.00 6.90±0.09 (98.57) 6.92±0.08 (98.86) 6.85±0.13 (97.85)
Art 4 10.00 9.97±0.10 (99.70) 9.85±0.14 (98.50) 10.00±0.10 (100.00)
Art 5 5.00 5.18±0.12 (103.60) 5.20±0.19 (103.80) 4.86±0.16 (97.20)
Art 6 10.00 10.16±0.12 (101.60) 10.16±.012 (101.60) 10.14±0.12 (101.40)
Art 7 0.00 –0.02±0.03 (–) −0.02±0.04 (−) −0.03±0.12 (–)
Art 8
Unk 1a
Unk 2
Unk 3
Unk 4
Unk 5
0.00
0.00
9.00
11.00
13.00
11.00
–0.03±0.03 (–)
–0.32±0.13 (–)
8.75±011 (97.22)
10.63±0.09 (96.64)
12.73±0.07 (97.92)
11.27±0.12 (102.45)
−0.01± 0.04 (−)
−0.31±0.13 (−)
9.34±0.13 (103.78)
10.51±0.08 (95.54)
12.61±0.07 (105.08)
11.26±0.10 (102.36)
−0.05±0.13 (–)
−0.46±0.20 (–)
8.52±0.17 (94.66)
10.53±0.12 (95.73)
13.56±0.11 (104.31)
10.71±0.13 (97.36)
x̅ 99.96 101.40 99.21
a

Art is artificial samples and Unk is unknown samples.

b

The reported values of standard deviations (±S.D.) are obtained from four replicates. Recovery percentages are shown in parentheses.